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Abstract 
As an approach toward identification and isolation of cellular proteins that may act as substrates or effecters of the SRC-family of protein-tyrosine 
kinases. fusion proteins containing noncatalytic elements of two highly related SRC-family members were tested for their ability to recognize distinct 
molecules present in lysates of cells known to normally express both enzymes. Our results demonstrate differences of protein binding between the 
SH2 elements of FYN and FGR kinases, but do not discriminate proteins binding to their SH3 domains. 
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1. Introduction 
The SRC family of oncogenes consists of cytoplasmic 
protein-tyrosine kinases predominantly expressed in he- 
matopoietic cells. These enzymes all share the ability to 
induce malignant ransformation when expressed ectopi- 
tally in murine NIH 3T3 cells, and emerging evidence 
suggests that they normally play a critical role in 
transducing signals from the extracellular environment 
to intracellular pathways. A catalytic domain which 
phosphorylates proteins exclusively on tyrosine residues, 
and three noncatalytic elements [l], believed to regulate 
enzyme action, represent he primary structural features 
of the family. Noncatalytic elements, designated SRC 
homology domains 2 and 3 (SH2 and SH3, respectively) 
are highly related within the SRC family, and more dis- 
tantly related versions are found in other proteins [2]. 
SH2 and SH3 domains coexist in phospholipase C-y 
(PLC-y) [3], RAS GTPase-activating protein (GAP) [4], 
and the p85 subunit of phosphatidylinositol-3-kinase [5], 
as well as a number of proteins having no known enzy- 
matic activity [6-91. SH2 and SH3 elements also appear 
independently. 
The function of SH2 appears to involve mediating the 
physical association of SH2 containing molecules to ty- 
rosine phosphorylated proteins [lO-121. On the other 
hand, a recently described protein, 3BP-1, which binds 
SH3 of the ABL tyrosine kinase [13], has sequence simi- 
larity to BCR and GAP-rho, suggesting a linkage be- 
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tween G-protein regulated pathways and protein tyro- 
sine kinases [14]. In the present report, we have directly 
investigated the specificity of SH2 and SH3 interactions. 
Our results demonstrate that even closely related SH2 
and SH3 elements pecifically recognize distinct proteins. 
2. Materials and methods 
2.1. Cells and antibodies 
Propagation of NIH 3T3 murine fibroblasts transformed with FYN 
has been described previously [15]. HL60 cells [16] were maintained in 
RPM1 1640 medium containing 10% FBS. Exponentially growing 
HL60 cells were subcultured at a density of 5 x lo4 cells/ml and where 
indicated, were treated with retinoic acid for 48 h at a concentration 
of 10m6 M to induce their differentiation. Cells were lysed in phosphate 
buffered saline (PBS), pH 7.2, which also contained 5 mM EDTA, 10% 
glycerol, 1% Triton X-100, 1 mM sodium orthovanadate, 1mM phen- 
ylmethanesulfonyl fluoride, 5 pg/ml aprotinin and 50 &ml leupeptin. 
Lysates were clarified by centrifugation at 14,000 x g for 20 min, and 
were biotinylated at room temperature for 30 min with gentle shaking 
by incubation with 20 pug N-hydroxysuccinimidobiotin dissolved in 10 
~1 N,N-dimethylformamide per mg of cell protein. The reaction was 
quenched by the addition of 2 ~1 ice cold 1 M Tris-HCl, pH 7.5, per 
mg cell protein. Biotinylated PY20 (ICN Biochemicals, CA), 4GlO 
(UBI Inc., NY) and 162 (Boehringer Manheim, IN) monoclonal anti- 
bodies capable of recognizing phosphotyrosine residues were used for 
immunoblots. 
2.2. Fusion proteins 
Protein elements were expressed in Escherichia coli HB 101 trans- 
formed with pGEX-2T based vectors 1171. Fusion uroteins consisted of 
the amino-terminal region of glutathiond-4transferase linked to FGR 
or FYN SH2 or SH3 elements. DNAs encoding SH domains were 
obtained by gel purification of human FGR cDNA components [18]. 
HindII-Sty1 and BstEII-Hind11 fragments of human c-FGR repre- 
sented SH2 (residues 137-253) and SH3 (residues 79-136) domains, 
respectively. Similarly, the HindII-XhoI fragment of human FYN 
cDNA [19] contained its SH2 domain, (residues 142-262). A PCR 
0014-5793/94/%7.00 0 1994 Federation f European Biochemical Societies. All rights reserved. 
SSDI 0014-5793(93)El508-J 
184 0.M. Rivero-Lezcano. XC. RobbinslFEBS Letters 338 (1994) 183-186 
reaction using the oligonucleotide S-GCGTGGATCCGCCCTT- 
TATGAC-3’ created a BamHI restriction site at FYN nucleotide 635. 
The BumHI-Hind11 fragment of this construct, containing the FYN 
SH3 domain (residues 89-141) was gel purified and ligated to BumHI- 
SmaI cut pGEX-2T DNA. Other SH encoding DNAs were blunt-end 
ligated into pGEX-2T. For the expression of the fusion protein, cultures 
were processed by the technique described by Lavan, et al. [20]. Yields 
were 4-8 pug of fusion protein/@ packed agarose beads as measured by 
elution of bound protein with 4% SDS. Bacterial fusion protein (12-15 
pg) were incubated for 1 h at 4°C with 1 mg of mammalian cell lysate 
unless otherwise indicated. Beads were washed twice with a buffer 
containing 0.2 M Tris-HCl, pH 7.5 and 150 mM NaCl before elution 
of proteins binding to SRC homology domains by boiling in Laemli 
loading buffer. 
21 
2.3. Protein blotting and detection 
Proteins were fractionated by electrophoresis n polyacrylamide gels, 
transferred by electroblotting to polhinylidene- di&oiide (PVDF) 
(Millipore, MA) membranes, and blocked by incubation with a buffer 
containing 10 mM Tris-HCI, pH 7.4, 150 mM NaCl (TN) and 4% 
bovine serum albumin fraction V (BSA). Streptavidin coupled to horse- 
radish peroxidase (HRP) (4 &ml) (Pierce, IL) was added to fresh 
blocking buffer, and filters were incubated an additional hour at room 
temperature. After extensive washing in TN buffer with 0.4% BSA, 
proteins were detected by enhanced chemiluminiscence (ECL) (Amer- 
sham, UK) following the manufacturer’s instructions. 
. 
Fig. 1. Specificity of cellular protein binding to noncatalytic elements 
of p59FYN expressed in bacteria as a GST-fusion protein. Lysates from 
FYN-transformed cells were labeled with biotin, incubated in the pres- 
ence of FYN SH2 or SH3 domains or GST and analyzed as described 
in Section 2. Prominent binding proteins are indicated at the right 
together with their corresponding molecular masses. Specificity of bind- 
ing to SH elements as well as nonspecific binding for each of these 
prominent proteins is also shown. 







3.1. Detection of cellular proteins that specifically 
associate with SH2 and SH3 domains 
To explore the possibility that protein-protein interac- 
tions could be used directly for the identification of can- 
didate substrates or effecters for SRC-family kinases, 
whole cell lysates from FYN transformed cells were la- 
beled with N-hydroxysuccinimidobiotin. Fusion proteins 
bearing FYN SH2 or SH3 domains were prepared from 
bacterial extracts, coupled to agarose beads and incu- 
bated with biotinylated cell extracts. Nonspecific binding 
in the assay was defined as those cellular proteins that 
bound only the GST portion of the fusion protein. As 
shown in Fig. 1 (lane 1) proteins associating with GST 
included predominant bands of 48 and 25 kDa as well 
as a number of other minor proteins. When these same 
lysates were incubated with a fusion protein containing 
FYN SH2 (Fig. lB, lane 2), specific binding proteins of 
114,94 and 68 kDa, among others, were detected. Simi- 
larly, a band of 64 kDa was observed as a specific FYN 
SH3 binding protein (Fig. 1, lane 3). Thus, proteins iden- 
tified as SHZbinding differed in size from SH3-binding 
species. We conclude that this procedure is capable of 
scoring cellular proteins that specifically bind to FYN 
SH2 or SH3 domains. 
3.2. Differential binding to SH2 and SH3 domains of 
FYN and FGR gene products 
The protein product of the FYN proto-oncogene is 
expressed in a wide variety of cell types, including fibrob- 
lasts and hematopoietic ells [21]. In contrast, the FGR 
gene product is normally expressed only in mature my- 
elomonocytic ells [22,23]. To determine whether specific 
association with analogous domains of these highly re- 
lated proteins could be demonstrated, we examined bind- 
ing in lysates from HL60 cells, a lineage where both FYN 
and FGR proteins are normally expressed. Expression 
of p55”-FGR only in HL60 cells induced to differentiate 
[23] prompted us to examine lysates from untreated as 
well as retinoic acid treated cells. When proteins binding 
to FYN or FGR SH2 were compared, we observed 
bands in common as well as proteins binding specifically 
to the FYN SH2 domain. As shown in Fig. 2A (lanes 6 
to 9), a doublet of 95 kDa appeared in lanes containing 
either FYN or FGR SH2 binding proteins. Protein 
bands of 60 and 70 kDa appearing in lane 6 were not 
reproducibly observed and therefore are not categorized 
as specific FGR SH2 binding proteins. In contrast, spe- 
cific FYN SH2 binding proteins ~114, p70 and p51 were 
observed. None of these proteins was detected in associ- 
ation with only the GST portion of the fusion protein. 
Although no major change in the pattern of binding 
proteins was observed in lysates of untreated as com- 
pared to retinoic acid treated cells, the signal intensities 
of ~95 and ~51 were stronger when differentiated cell 
lysates were analyzed (compare lanes 7 and 9). 
The pattern of proteins observed to associate with 
FGR or FYN SH3 domains was substantially different 
from that observed with SH2 domains (Fig. 2A). How- 
ever, no distinct bands could be observed to associate 
specifically with either FYN or FGR SH3 domains in 
differentiated or undifferentiated cells. FYN SH3 bind- 
ing proteins appeared to be identical to those associating 
with FGR SH3 and a protein of 60 kDa was the most 
intense of the SH3 binding proteins. 
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Fig. 2. (A) Identification of HL60 cell proteins that specifically bind 
FYN and FGR SH2 and SH3 elements. Protein extracts of untreated 
(-) or retinoic acid (RA) treated (+) HL60 cells were biotinylated, 
incubated with fusion proteins and analyzed as described in Section 2. 
Molecular masses of biotinylated standards are shown in kilodaltons 
at the right. Arrowheads between lanes indicate the more prominent 
SH-element binding proteins which are shown with their corresponding 
molecular masses. (B) Nonbiotinylated protein extracts from the same 
cultures described in Panel A were incubated with the fusion proteins 
shown and visual&d by immunoblotting with biotinylated anti- 
phosphotyrosine antibody. Molecular size standards are shown at the 
left in kilodaltons. Arrows at the right indicate prominent SH-element 
binding proteins which are shown with their corresponding molecular 
masses. 
3.3. Tyrosine phosphorylation of proteins binding to 
non-catalytic domains 
Previously, proteins binding to SH2 elements have 
been shown to require phosphorylation on tyrosine resi- 
dues [IO,1 11. To determine whether proteins binding to 
FYN or FGR SH2 domains were tyrosine phos- 
phorylated, associating proteins were fractionated by 
electrophoresis and immunoblotted using a biotinylated, 
affinity purified anti-phosphotyrosine antibody (PY20) 
as a probe. As shown in Fig. 2B, most of the biotinylated 
proteins detected as SH2 binding were also scored by 
anti-PY. No differences were found when compared with 
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the anti-PY monoclonal antibodies lG2 and 4GlO (data 
not shown). SH2 binding proteins of 114 and 51 kDa 
(lanes 1 and 3) as well as lower molecular weight proteins 
were detectably phosphorylated on tyrosine. The ~51 
molecule appeared to be more highly phosphorylated in 
differentiated as compared to untreated cells. In con- 
trast, p70 and ~95, the most prominent SH2 binding 
proteins observed in Fig. 2A, were not detected as tyro- 
sine phosphorylated species. Furthermore, a phospho- 
protein of 59 kDa, not recognizable as a biotinylated 
SH2 binding protein, was readily detected by anti-PY. 
Taken together, these findings provide evidence that not 
all SH2 binding proteins are tyrosine phosphorylated. 
Recent studies of BCR association with ABL SH2 [24] 
have shown that its phosphorylation on serine residues 
is important for binding to ABL SH2. A similar mecha- 
nism may account for the binding of molecules like p70 
and ~95 to the FYN and FGR SH2 domains. 
The only phosphorylated SH3 binding protein de- 
tected was a protein of 60 kDa that does not bind SH2 
despite its tyrosine phosphorylation. This protein ap- 
pears to have higher affinity for FGR SH3 than for FYN 
SH3 (Fig. 2B). Extended electrophoresis (Fig. 2B, at left) 
revealed that ~60 migrates as a doublet, which could 
represent either two forms of the same protein or two 
different proteins. Although we cannot formally rule out 
the possibility that ~59 is a component of the p60 band 
shown in Fig. 2A, we conclude that the ~59 phosphopro- 
tein is distinct from ~60. 
4. Discussion 
Previous methods utilized for the study of proteins 
that physically interact with noncatalytic SH2 and SH3 
domains have relied either on the availability of antibod- 
ies recognizing the protein under study [25] or have re- 
quired the use of directly or indirectly labeled SH do- 
mains for binding to cellular proteins immobilized on 
filters [ 121. We addressed the question of specific binding 
by incubating labeled cell lysates with SH-fusion proteins 
coupled to agarose beads. As a detection method, we 
chose to label cellular lysates with biotin for several rea- 
sons. First, our interest focused upon the entire comple- 
ment of proteins expressed in cells at steady state. Meta- 
bolic labeling approaches were deemed unsatisfactory 
because of their inherent problems providing molecules 
of uniform detectability. In addition, it was important 
for us to avoid labeling tyrosine residues, since tyrosine 
has been implicated in SH2 domain recognition. Thus, 
we used acylating agents like N-hydroxysuccinimide s- 
ters, which are reactive toward amines, mainly on ly- 
sines. This approach can be used with ‘*jI or biotine 
[26,27]. Theoretically both labeling techniques label the 
proteins with the same efficiency since each utilizes the 
same mechanism for coupling. Furthermore, the sensi- 
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tivity of detection with the ECL reagent is comparable 
to ‘25I [28]. 
The array of bands observed to bind SH3 domains was 
similar whether SH3 was derived from FYN or FGR and 
appeared to depend little on the source of cellular pro- 
tein. We view it likely that the high degree of amino acid 
identity between SH3 elements from FGR and FYN 
proteins (83%) accounts for the similarity of patterns 
observed. A molecule of 60 kDa was identified as a spe- 
cific SH3 binding protein, but surprisingly was found to 
be phosphorylated on tyrosine residues in HL60 cells. 
Thus, an abundant, widely distributed protein capable of 
specifically binding to SH3 elements of SRC family ki- 
nases is phosphorylated on tyrosine but does not bind to 
SH2 domains. 
Distinct proteins associating with the SH2 domains of 
either FGR or FYN kinases demonstrated binding spec- 
ificity between highly related SH2 elements. A 51 kDa 
molecule was associated with the FYN SH2 element but 
not with that of FGR, and represented the major differ- 
ence found between immature and differentiated HL60 
cells. We cannot determine at this juncture whether en- 
hanced expression of p51 in differentiated cells or a 
change in its affinity for FYN SH2 accounts for its in- 
creased detectability in our assay. Other examples of 
binding specificity included ~114 and ~70, both of which 
bound FYN but not FGR SH2. Whereas binding of 
tyrosine phosphorylated proteins to SH2 elements is well 
established [lO,l 11, the novelty of this finding relates to 
the degree of binding specificity observed between two 
such closely related SH2 domains. 
Acknowledgments: Octavia M. Rivero-Lezcano gratefully acknowl- 
edges support from the Fulbright division of the Spanish Ministry of 
Health and Consumer Affairs, Las Palmas University Foundation, and 
Ahemon, Inc. We also thank Silvio Gutkind for helpful discussions and 
Jeanne Sameshima for her expert advise and technical assistance. 
[I] Eiseman, E. and Bolen, J.B. (1990) Cant. Cells 2, 303-310. 
[2] Koch, CA., Moran, M.F., Anderson, D., Liu, X., Mbamalu, G. 
and Pawson, T. (1992) Mol. Cell. Biol. 12, 13661374. 
[3] Stahl, M.L., Ferenz, C.R., Kelleher, K.L., Kriz, R. W., and Knopf, 
J.L. (1988) Nature 332, 2699272. 
[4] McCormick, F. (1989) Cell 56, 5-8. 
[5] Kazlauskas, A. and Cooper, J.A. (1990) EMBO J. 9, 327993286. 
[6] Reichman, C.T., Mayer, B.J., Keshav, S. and Hanafusa, H. (1992) 
Cell Growth Differ. 3, 451460. 
[7] Lehmann, J.M., Riethmuller, G. and Johnson, J.P. (1990) Nucleic 
Acids Res. 18, 1048. 
[S] Clark, S.G., Stern, M.J. and Horvitz, H.R. (1992) Nature 356, 
340-344. 
[9] Bustelo, X.R., Ledbetter, J.A. and Barbacid, M. (1992) Nature 
356, 68-71. 
[lo] Matsuda, M., Mayer, B.J., Fukui, B.J. and Hanafusa, H. (1990) 
Science 248, 153771539. 
[ll] Matsuda, M., Mayer, B.J. and Hanafusa, H. (1991) Mol. Cell. 
Biol. 11, 1607-1613. 
[12] Mayer, B.J., Jackson, P.K. and Baltimore, D. (1991) Proc. Natl. 
Acad. Sci. USA 88, 627631. 
[13] Cicchetti, P., Mayer, B.J., Thiel, G. and Baltimore, D. (1992) 
Science 257, 803-806. 
[14] Lowenstein, E.J., Daly, R.J., Batzer, A.G., Li, W., Margolis, B., 
Lammers, R., Ullrich, A., Skolnik, E.Y., Bar-Sagi, D., and 
Schlessinger, J. (1992) Cell 70, 431442. 
[15] Kawakami, T., Kawakami, Y., Aaronson, S.A. and Robbins, KC. 
(1988) Proc. Natl. Acad. Sci. USA 85, 387&3874. 
[16] Collins, S.J., Gallo, R.C. and Gallagher, R.E. (1977) Nature 270, 
347-349. 
[17] Smith, D.B. and Johnson, K.S. (1988) Gene 67, 3140. 
[18] Katamine, S., Notario, V., Rao, C.D., Miki, T., Cheah, M. S.C., 
Tronick, S.R. and Robbins, K.C. (1988) Mol. Cell. Biol. 8, 259- 
266. 
[19] Kawakami, T., Pennington, C.Y. and Robbins, K.C. (1986) Mol. 
Cell. Biol. 6, 41954201. 
[20] Lavan, B.E., Kuhn& M.R., Garner, C.W., Anderson, D., Reddjik, 
M., Pawson, T. and Lienhard, G.E. (1992) J. Biol. Chem. 267. 
11631-11636. 
[21] Kawakami, Y., Furue, M., Kawakami, T. (1989) Oncogene 4. 
389-391. 
[22] Ley, T.J., Connally, N., Katamine, S., Cheah, M.S.C., Senior, 
R.M. and Robbins, K.C. (1989) Mol. Cell. Biol. 9, 92-99. 
[23] Notario, V., Gutkind, J.S., Imaizumi, M., Katamine, S., and Rob- 
bins, K.C. (1989) J. Cell. Biol. 109, 3129-3136. 
[24] Pendergast, A.M., Muller, A.J., Havlik, M.H., Maru, Y.. and 
White, O.N. (1991) Cell 66, 161-171. 
[25] Moran, M.F., Koch, C.A., Anderson, D., Ellis, C., England, L., 
Martin, G.S. and Pawson, T. (1990) Proc. Natl. Acad. Sci. USA 
87, 8622-8626. 
[26] Bolton, A.E. and Hunter, W.M. (1973) Biochem. J. 133, 529-538. 
[27] Becker, J.M., Wilchek, M. and Katchalski, E. (1971) Proc. Natl. 
Acad. Sci. USA 68, 20642067. 
[28] Heinicke, E., Kumar, U., and Munoz, D.G. (1992) J. lmmunol. 
Methods 152. 2277236. 
